Quick Read
- Theranostics combines diagnosis and treatment using targeted radiation
- HCG Cancer Centre offers Lutetium-177 therapy for metastatic prostate cancer and Radioiodine therapy for thyroid cancer
- Patients can now access advanced theranostics in Kenya without travelling abroad
- Local treatment means faster access, lower costs, and care closer to home
- Book a consultation to see if theranostics is right for you
For many years, patients in Kenya who needed advanced cancer treatments often had to travel abroad. The cost, distance, and time away from family made it difficult to access specialised therapies.
That is changing with the introduction of theranostics to Kenya at HCG Cancer Centre.
Our dedicated Theranostics Clinic now brings world-class precision cancer treatment closer to home, helping patients receive advanced care without leaving the country.
What is Theranostics?
Theranostics is a modern approach that combines therapy and diagnostics. It uses the same targeted medicine first to locate cancer cells and then to deliver precise radiation treatment.
The guiding principle is simple yet powerful:
See what you treat, and treat what you see.
This method allows doctors to confirm the presence of a specific target on cancer cells before delivering treatment, making care more accurate and personalised.
(New to this topic? Read our earlier article: Theranostics in Kenya: Precision Cancer Treatment at HCG Cancer Centre)
Advanced Theranostics Treatments at HCG Cancer Centre
HCG Cancer Centre currently offers two key theranostics treatments:
Lutetium-177 Therapy for Metastatic Prostate Cancer
This treatment targets a protein called PSMA, which is commonly found on prostate cancer cells. After a specialised PET scan confirms the target, the Lutetium-177 PSMA therapy is administered. It helps control cancer that has spread and improve patients’ quality of life.
Learn more about prostate cancer treatment at HCG – How To Access Lutetium-177 Therapy at HCG CCK in Nairobi.
Radioiodine Therapy for Thyroid Cancer
Radioiodine therapy is one of the most established forms of theranostics. The radioactive iodine is taken up almost exclusively by thyroid cancer cells, making it a highly targeted and effective treatment option.
Why Choosing Theranostics in Kenya Matters
Accessing theranostics locally at HCG Cancer Centre offers several important advantages:
- Faster start to treatment without international travel delays
- Patients remain close to family and support systems
- Reduced costs related to flights, accommodation, and overseas care
- Easier and more continuous follow-up care
By offering these advanced treatments in Kenya, HCG Cancer Centre is improving access to precision cancer care for patients across the region.
A New Standard in Precision Cancer Care
Theranostics represents a significant step forward in targeted cancer treatment. As new therapies continue to emerge, HCG Cancer Centre remains committed to bringing the latest options to patients in Kenya safely and efficiently.
Call to Action
Is theranostics the right treatment option?
For patients diagnosed with advanced prostate cancer, thyroid cancer, or other conditions that may benefit from targeted radionuclide therapy, the specialist team at HCG Cancer Centre is ready to assist.
Theranostics is now available at HCG Cancer Centre.
